Publicación
Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.
Ver todas las publicaciones
Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.